Innovation is the cornerstone of AbbVie’s business as a global biopharmaceutical company. Their focus is on developing medicines that can provide strong clinical performance, measurable patient benefit and economic value, particularly in areas where there is significant need, such as hepatitis C, neuroscience, immunology, oncology, chronic kidney disease and women’s health.
AbbVie combines advanced science, global capabilities and passion to provide innovative therapies that help people manage some of the most serious health conditions.
member
As part of the Global Biotech Week 2023 celebrations, BAM is not only celebrating the success stories within Manitoba's thriving $9.9 billion biotech industry but also taking a significant step towards securing its future.
Newly launched MY Sleep Scoring API provides free access to leading sleep analysis metric, accelerating research into the clinical management of disrupted sleep.
Provinces and territories will have access to updated COVID-19 vaccines for their respective fall vaccination campaigns
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.